Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

BACKGROUND: Warfarin and similar vitamin K antagonists have been the standard therapy for patients with mechanical or biological valve prosthesis and atrial fibrillation (AF). Even with the appropriate use of therapy, some studies have reported that there is a high incidence of thromboembolic events...

Descripción completa

Detalles Bibliográficos
Autores principales: Duraes, Andre Rodrigues, Roriz, Pollianna DS, Bulhoes, Fabio V, Nunes, Bianca DA, Muniz, Juliana QV, Neto, Italvar NDCR, Fernandes, Andre MS, Reis, Francisco JFBD, Camara, Edmundo JN, Junior, Erenaldo DSR, Segundo, Deusdeth TS, Silva, Felipe Pinho E Albuquerque, Aras, Roque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications Inc. 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://www.ncbi.nlm.nih.gov/pubmed/24691436
http://dx.doi.org/10.2196/resprot.3014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://www.ncbi.nlm.nih.gov/pubmed/24691436
http://dx.doi.org/10.2196/resprot.3014

Ejemplares similares